Neonatal encephalopathy (NE) is a descriptive term for clinical conditions characterized by neurological dysfunction including difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and seizures.
Introduction
Neonatal encephalopathy (NE) is a descriptive term for clinical conditions characterized by neurological dysfunction including difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and seizures.
1 NE has a complex and alterations or visual problems including blindness. 2 The retina, as an extension of the brain, is also sensitive to hypoxia.
3,4
It is well known that perinatal HI and the resulting NE impact on vision in term newborns. Visual defects related to hypoxic brain damage are currently the most common and potentially preventable cause of visual impairment in children in developed countries. [5] [6] [7] [8] The prevalence of visual impairment in children with HI injury may be as high as 66 and 94%. 9 Most of the visual dysfunctions attributed to hypoxic-ischemic brain injury are related to retinal damage. Previous studies have suggested that visual loss in perinatal HI patients is associated with retroretinal and intracerebral visual pathways. 5, 7, [10] [11] [12] [13] [14] Subsequent experimental studies revealed that ischemic retinal damage (IRD) is another contributing factor for visual impairments in developing neonatal retina.
9,15
Perinatal HI can itself cause intraocular hemorrhage (IOH), 16 which may cause local IRD through several mechanisms in addition to general retinal ischemia. Retinal hemorrhages in perinatal HI patients, as a retinal examination finding, are pointed out in a small number of publications. 16, 17 In the era of therapeutic hypothermia (TH), there is no data on retinal ophthalmoscopic examination findings in cooled babies diagnosed with NE.
In this study, we aimed to evaluate the early retinal ophthalmoscopic findings in moderate-to-severe NE who underwent TH. We assessed the relationship between early retinal findings and coagulation parameters, blood/blood product transfusion requirement, magnetic resonance imagingmagnetic resonance spectroscopy (MRI-MRS) and amplitudeintegrated electroencephalography (aEEG) findings.
Patients and Methods
This cross-sectional cohort study was approved by Erciyes University Clinical Research Ethics Committee. Informed written consent was taken from all the parents.
A total of 41 newborn infants who were followed up at neonatal intensive care unit (NICU) of our hospital during February 2015 to August 2016 were included in the study. The inclusion and exclusion criteria were depicted in ►Table 1.
18
Clinical severity of NE was determined using the Sarnat and Sarnat criteria. TH was started as a standard care in all babies that meet the criteria within 6 hours after birth using total body cooling device (Arctic Sun 5000, Medivance, CO, USA) in NICU settings. According to our clinical protocol, targeted core (rectal) temperature is 33.5°C for 72 hours. During rewarming period, targeted hourly body temperature rise rate is 0.25°C. According to the protocol of our clinic, an umbilical vein catheter was inserted to all patients admitted to the NICU and no heparinized fluid was given for its continuity.
Raw EEG and aEEG recordings were started simultaneously with TH and continued until the end of the rewarming period (Nicolet-NicoletOne, Natus, CA, USA). A pattern classification was used for interpretation of aEEG according to the previously published data by Hellström-Westas L et al. 19 At the end of the first 24 hours of TH, aEEG patterns were evaluated. Continuous and discontinuous background pattern in aEEG tracing was defined as normal. Other types of tracings (burt-suppression, low voltage, and flat trace) were regarded as abnormal. Infants that meet criteria A and B and do not meet the exclusion criteria given below will be included for the study
In case the unit has cerebral function monitoring facility and a trained neonatologist to apply and interpret the aEEG, the below-given criteria C will be used as an additional help to recruit the newborns into the study 21
Binocular Indirect Ophthalmoscopic Examination
Binocular indirect ophthalmoscopic examination (BIOE) was performed by an experienced pediatric ophthalmologist blinded to the neonatal course and MRI-MRS scanning findings by using BIO when TH and rewarming implementation was terminated, and the patients were clinically stabilized. Mydriatic eye drops to dilate the pupils are routinely administered before retinal examinations. A combination of cyclopentolate 0.2%, an anticholinergic drug, and phenylephrine 1%, an α-adrenergic drug, was used to dilate the pupil.
The newborns with IOH lesions were re-examined every 1 or 2 weeks until the lesions were resolved completely.
MRI-MRS Scanning
MRI and MRS scanning were performed within the first 2 weeks of life, after the TH protocol had been completed and patient stability confirmed. MRI and MRS scanning were performed after sedation. First, passive sedation with breast milk or a pacifier was tried, if needed, oral/rectal chloral hydrate or oral midazolam was given for self-ventilating infants or intravenous midazolam for those who were mechanically ventilated. Neonatal intensive care including inotrope and/or mechanical ventilation support was continued throughout when indicated, and monitoring including pulse oximetry, skin temperature, and apnea alarm was done. A pediatrician and a NICU nurse were always present during MRI-MRS scan.
An 8-channel transmit/receive head coil of a 1.5T Magnetom Sonata system (Siemens AG, Erlangen, Germany) was used for proton (1H) MRS and MRI. MRI protocol including MRI T2 relaxometry and 1H MRS was done as previously described by Shanmugalingam et al. 23 Diffusion-weighted imaging and susceptibility-weighted imaging were gained. We reported specifically the data related to intracranial hemorrhage (ICH) and/or infarcts obtained from MRI scan in this study. Metabolite peak-area ratios including lactate/N-acetylaspartate (Lac/NAA), Lac/Cr, Lac/Cho, NAA/Cr, NAA/Cho, and Cho/Cr were measured from the 8-mL cubic PRESS voxel and centered on the thalami and the midline by using the sagittal image (TE 270 milliseconds, TR 2 seconds spectrum). Lac/ NAA ratio, which is a useful predictor of adverse outcomes, was used for the evaluation of the severity of the brain damage.
23 Similar thresholds for Lac/NAA peak-area ratios as those used by Shanmugalingam et al were used to predict neurodevelopmental outcome. 23 Lac/NAA peak-area ratio of 0.23, 0.24 to 0.41, and >0.42 were classified as normal, mild-to-moderate, and severe respectively.
Statistical Analysis
Data entry and analyses were made using IBM SPSS Statistics, version 20. Descriptive statistical methods (mean and standard deviation), chi-square (χ 2 ), and Fisher's exact test were used for qualitative data determination. Data were expressed as mean AE standard deviation, unless otherwise specified.
Distributions of the data were tested by Shapiro-Wilk test. Comparisons between the groups were made by the Mann-Whitney U test and Kruskal-Wallis one-way analysis. A p-value of less than 0.05 was considered statistically significant.
Results
During the study period, 41 infants were enrolled in the study, but 10 of them were excluded from the study because they died before BIOE and/or MRI-MRS scanning. The study was completed with the remaining subjects (n ¼ 31), who were born at a mean gestational age of 38.8 ( AE 1.4) weeks and had a birth weight of 3190 AE 467.4 g. One patient was diagnosed with postnatal collapse. The anthropometric and descriptive features of the subjects are shown in ►Table 2. Mode of delivery and sex were not related to BIOE findings in our patients.
Initial coagulation status including PLT counts, PT, aPTT, and INR results are shown in ►Table 2. A total of 12 (38.7%) patients had disturbed coagulation status in the initial test results.
During TH and rewarming period, 7 (22.6%) patients were given PLT transfusion(s), 16 (51.6%) patients required FFP transfusion(s) due to abnormal test results and some active hemorrhages involving pulmonary and gastrointestinal system. The number of patients who required both PLT and FFP transfusion was 7 (22.6%) (►Table 2).
BIOE was performed at mean 11.8 ( AE 7.9) days. The number of patients with abnormal BIOE findings was 13 (41.9%). Ten of them (77%) had IOH findings in optic disc (n ¼ 2), retina (RH) (n ¼ 7), or vitreous (VH) (n ¼ 1). BIOE findings were summarized in ►Table 3. IOHs were detected as more bilaterally than unilaterally (n ¼ 7, n ¼ 3, respectively). All hemorrhages resolved within 4 weeks, except in one patient with unilateral VH which persisted up to 10 weeks. ►Table 4 shows the relationships between BIOE findings and both laboratory and imaging findings.
The number of patients with no abnormal retinal findings was 18 (58.1%) and three patients had abnormal retinal findings other than hemorrhage. Namely, two patients had IRD findings such as stage 1 retinopathy of prematurity (ROP) and dilated retinal vessels, and one patient had finding of structural retinal disorder, which may be secondary to congenital infection or genetic disorder.
Initial coagulation tests and PLT count were not related to hemorrhagic BIOE findings. Additionally, presence of requirement of PLT and/or FFP transfusion(s)
MRI-MRS scanning were performed at 8.1 ( AE 2.2) days. In six (%19.4) patients, subdural and/or dural and/or parenchymal hemorrhage was detected, and in four (12.9%) patients brain infarct was detected in MRI scanning. The types of ICHs are shown in ►Table 2.
Lac/NAA peak-area ratios on MRS were within normal range in eight (25.8%) patients. Metabolite peak-area ratios were consistent with mild-to-moderate outcome in 9 (29%) patients and with severe outcome in 14 (45.2%) patients. There was no statistically significant relationship between MRS (Lac/NAA peak-area ratio) and BIOE findings (p > 0.05) (►Table 4).
MRS features of patients with subdural hemorrhage were as follows; one patient (16.7%) had normal MRS findings, two patients (33.3%) had mild-to-moderate MRS findings, and three patients (50%) had severe MRS findings. Three of the patients (75%) with severe MRS findings had brain infarct. MRI findings including ICH and infarcts were not related to BIOE findings (p >0.05), (►Table 4).
Discussion
Earlier studies claimed that visual defects in the braindamaged infants were attributed to the so-called cortical visual impairment caused by pathologies in intracerebral visual pathways which is a large proportion of the human brain's neural substance (i.e., the optic nerves, optic radiations, primary visual cortex, visual associative cortical areas, and/or visual attention pathways).
5,7,10-14 Damage to several these different structures can result in significant visual disability. 11 Clinical manifestations of visual disability are associated with nonvisual neurologic complications, as well as prognosis greatly depending on the site(s) of brain injury.
5
Perhaps, for this reason, earlier guidelines proposed the ophthalmologic evaluation for neonates underwent moderate-to-severe NE because of the possibility of damage in posterior visual pathways and secondary amblyopia but not for possible retinal damage. 25 Recent experimental rodent studies revealed that severity of IRD which occurs during HI is unrelated to the severity of HI injury, and IRD may be another contributing factor for visual impairments.
9,15
IOHs and their effects on developing retina in neonates who underwent TH are usually overlooked by clinicians. A current guideline does not recommend routine retinal examination to evaluate IOH before discharge for babies with NE.
26
IOH caused by perinatal HI 16, 17 can itself result in IRD. Either small IOHs itself due to locally disturbed circulation in hemorrhagic area or increased intraocular pressure created by excessive IOH causing disturbed retinal circulation, such as VH or extensive RH, can contribute to an increase in severity of IRD. Excessive IOHs might cause secondary amblyopia of the involved eye in the future life of newborns. Furthermore, increased intraocular pressure created by excessive IOH can contribute to an increase in IRD through a similar pathophysiology in acute glaucoma. 24 The present study showed that the frequency of IOH is high in newborns with NE who underwent TH, being independent from severity of aEEG pattern, ICH, MRS findings, and disturbed coagulation status in this population. Among the potential causes of IOHs are perinatal HI, traumatic delivery, ICH, shaken baby syndrome, and neonatal coagulopathies. 16, 17 The incidence of neonatal IOH varies according to the timing of the examination being higher in those early-examined neonates. 16 In our study, we detected IOH in 32.2% (n ¼ 10) of our patients whose BIOE examinations were performed at 11.8 ( AE 7.9) days. This is more than a previous clinical study, where the IOH incidence was 5.5% at mean 11.5 days, 16 but the patient group of that study consisted of milder cases of NE compared with our study group. IOHs may be associated with ICH; during HI, disturbed cerebral vascular autoregulation results in raised intracranial pressure which in turn increases the retinal venous pressure. The risk of IOH is increased by retinal venous stasis, disturbed vascular fragility and fluctuating systemic arterial pressure during resuscitation in newborns. 27, 28 In our cases, there was no history of traumatic birth and mode of delivery was not related to IOH. ICH was detected on MRI in six (19.4%) patients and we did not find any relationship with IOH frequency and ICH. The absence of any relationship with frequency of ICH and IOH might be related to small numbers. In our study, all patients were clinically diagnosed with moderate-to-severe NE and underwent TH. We argue that moderate-to-severe NE despite the fact that the unknown frequency of ICH and IOH in dead patients might be an explanation for the high frequency of IOH detected in our patients. As all patients underwent TH, we cannot determine the possible effect of TH on IOH. 22 In another patient, dilated retinal vessels were detected which might be considered as IRD and/or retinal vascular stasis such as seen in diabetic retinopathy.
22,24
The retina has the highest oxygen expenditure per volume in the body. 22 The developing retina is highly sensitive to variation in oxygen levels and highly susceptible to oxidative damage by reactive oxygen species (ROS), as well as overproduced nitric oxide (NO) creating reactive nitrogen species (RNS). 9, 15, 22 NO is the most widespread intercellular messenger in the retina and nitric oxide synthesis (NOS) systems which are located predominantly at the inner margin of retina. 34, 35 Interestingly, NOS activity pattern in CNS is different from retina. Animal studies revealed that NOS isoforms activity in CNS is increased by hypoxia at early postnatal period and significantly declines thereafter. 31, 34, [36] [37] [38] In contrast, in the retina, induced longterm alterations in the activity of NOS systems by HI started at late postnatal stages and remained high for long time and early applied hypothermia had beneficial effects on these diverse retinal NOS systems. 34 We think that this unique activity of different NOS isoforms occurring at different times may be the reason for the lack of similarity of retinal and CNS damage severity after HI. In several studies, TH was shown to prevent IRD by inhibiting expressions of some factors that target for hypoxia-inducible factor-1β including nNOS, iNOS, vascular endothelial growth factor, and adrenomedullin (AM), and nitration of proteins. 22, 31, 32, 34 Although these beneficial effects of TH on IRD in animal studies are encouraging, there is no study in human newborns. The effect of TH on the increased risk of IOH in neonates with NE who underwent TH remains unclear. We believe that beneficial effects of TH on IRD might be limited due to increasing possibility of IOH resulted from multiple disturbances, as described above. We are aware of the limitations of the current study. The lack of retinal examination at the admission/before TH in patients with moderate-to-severe NE does not allow us to comment on the real frequency of IOH. Also, we were not able to do daily BIOE to prevent increased light exposure and stimulant for maximum neuronal protection. Wide variation in BIOE timing due to the fact that we have to wait for patients to be clinically stable is another limitation of study. In addition, the small number of patients and lack of control group caused inadequacy in determining the reason of the high rate of IOH in our patients. The data obtained from our work will be useful for future studies. We believe that further clinical studies are needed to evaluate retinal changes in newborns with NE. In addition, well-designed experimental studies would shed light on understanding the mechanisms of these disturbances and possible adverse or beneficial effects of TH on retinal changes in this specific group of newborns.
In conclusion, while TH reduces IRD caused by RNS and ROS, its effect on the increased frequency IOH is not clear. In this study, we found that the frequency of IOH is high and independent from ICH, coagulation status, and neurodevelopmental prognostic parameters including MRS findings as well as aEEG findings in neonates diagnosed with NE who underwent TH.
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